Novo Nordisk shares rise after Wegovy recommended by Britain's drug price regulator
The new recommendation will significantly expand access to Wegovy on the England's NHS.
Join Our Newsletter
Join our subscribers list to get the latest news, updates and special offers directly in your inbox
